INDIVIDUAL ARTICLE: Safety and Tolerability of Topical Agents for Actinic Keratosis: A Systematic Review of Phase 3 Clinical Trials

October 2021 | Volume 20 | Issue 10 | Supplement Individual Articles | s4s4 | Copyright © October 2021


Published online September 30, 2021

Jeffrey R. Rajkumar BS,a April W. Armstrong MD MPH,b Leon H. Kircik MDc

aUniversity of Illinois College of Medicine, Chicago, IL
bDepartment of Dermatology, University of Southern California, Keck School of Medicine, Los Angeles, CA
cIcahn School of Medicine at Mount Sinai, New York, NY; Indiana University Medical Center, Indianapolis, IN; Physicians Skin Care, PLLC, Louisville, KY; DermResearch, PLLC, Louisville, KY; Skin Sciences, PLLC, Louisville, KY